載入...
Treatment of Non Small Cell Lung Cancer: Overcoming the resistance to EGFR inhibitors
PURPOSE OF REVIEW: Testing for epidermal growth factor receptor (EGFR) mutations has become standard practice in treating patients with advanced nonsmall cell lung cancer (NSCLC). EGFR tyrosine kinase inhibitors (TKIs) are being offered as first line therapy in patients with EGFR activating mutation...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3277209/ https://ncbi.nlm.nih.gov/pubmed/22314615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e32834ec6a7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|